Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
Stephanie van de Wall, Kim Santegoets, Eline J.H. van Houtum, et al.
Trends in Immunology (2020) Vol. 41, Iss. 4, pp. 274-285
Closed Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Insights into the role of sialylation in cancer progression and metastasis
Christopher Dobie, Danielle Skropeta
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 76-90
Open Access | Times Cited: 238
Probing the binding specificities of human Siglecs by cell-based glycan arrays
Christian Büll, Rebecca Nason, Lingbo Sun, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 133
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 125
Endothelial Glycocalyx
Christopher Foote, Rogério N. Soares, Francisco I. Ramirez‐Perez, et al.
Comprehensive physiology (2022), pp. 3781-3811
Open Access | Times Cited: 82
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 76
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Jennifer Munkley
Cancers (2022) Vol. 14, Iss. 17, pp. 4248-4248
Open Access | Times Cited: 70
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 38
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer
Le Tang, Xiao Yang, Liwen He, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Mutant glycosidases for labeling sialoglycans with high specificity and affinity
Yunfei Li, Qi Tang, Xiangqian Guo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Natália Rodrigues Mantuano, Marina Natoli, Alfred Zippelius, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001222-e001222
Open Access | Times Cited: 93
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
Ying Xu, Guan-Hua Su, Ding Ma, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 87
Sialic acid O-acetylation: From biosynthesis to roles in health and disease
Eline A. Visser, Sam J. Moons, Suzanne B. P. E. Timmermans, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 2, pp. 100906-100906
Open Access | Times Cited: 80
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
Baihui Li, Bailu Zhang, Xuezhou Wang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Siglec Signaling in the Tumor Microenvironment
Eline J.H. van Houtum, Christian Büll, Lenneke A. M. Cornelissen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
Siglec receptors as new immune checkpoints in cancer
Michal A. Stanczak, Heinz Laübli
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101112-101112
Open Access | Times Cited: 61
Genetically encoded chemical crosslinking of carbohydrate
Shanshan Li, Nanxi Wang, Bingchen Yu, et al.
Nature Chemistry (2022) Vol. 15, Iss. 1, pp. 33-42
Open Access | Times Cited: 47
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112475-112475
Open Access | Times Cited: 38
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
Benjamin Smith, Anja Deutzmann, Kristina M. Correa, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 36
The role of macrophages in the tumor microenvironment and tumor metabolism
Pritam Sadhukhan, Tanguy Y. Seiwert
Seminars in Immunopathology (2023) Vol. 45, Iss. 2, pp. 187-201
Closed Access | Times Cited: 27
DNA hydrogels and nanogels for diagnostics, therapeutics, and theragnostics of various cancers
Iman Zare, Reza Taheri‐Ledari, Farhad Esmailzadeh, et al.
Nanoscale (2023) Vol. 15, Iss. 26, pp. 10882-10903
Closed Access | Times Cited: 27
Immunoengineering can overcome the glycocalyx armour of cancer cells
Sangwoo Park, Marshall J. Colville, Justin H. Paek, et al.
Nature Materials (2024) Vol. 23, Iss. 3, pp. 429-438
Open Access | Times Cited: 15
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco‐Moreno, Emily Archer Goode, et al.
EBioMedicine (2024) Vol. 104, pp. 105163-105163
Open Access | Times Cited: 15
Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors
Kelli A. McCord, Chao Wang, Mirjam Anhalt, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 315-330
Open Access | Times Cited: 13
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
Rong Xiao, Ye Tian, Jiwei Zhang, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 792-804
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top